How To Increase Access To Femtech Clinical Trials

Our planet has just as many women as men, but technology companies catering to women’s health needs own only a sliver of the global market. In 2019, Femtech — an industry focused on women’s healthcare software and technology solutions — earned $820.6 million in global revenue and raised $592 million in venture capital investments.¹ As a result of the rapid expansion of the Femtech industry, there has been an uptick in Femtech clinical trials as well.

This growth makes sense, as the cultural climate surrounding women’s issues, including health, has shifted dramatically in recent years. Women are sick of fighting for representation in healthcare and clinical research. Talking about and seeking help for women’s health issues is becoming more normalized. And women have more access to disposable income, smartphones, internet connections, and digital literacy than ever before.

When looking to enable broader participation in trials of all kinds, including Femtech, consider these potential solutions.